AGP Executive Report
Last update: an hour agoHemp Regulation: The US has delayed key federal hemp-definition changes until December 11, including the total-THC standard and per-container cap. A separate ban on synthetic cannabinoids still takes effect November 12. Medical Cannabis Markets: Glass House Brands secured GACP certification for two California farms, a step toward possible international medical-cannabis exports. MediPharm Labs also reported its first shipment of a CBD metered-dose inhaler to Panama. Public Health: Sint Maarten’s health minister is seeking PAHO guidance on cannabis policy, saying mental health and protections for vulnerable people must be considered alongside economic potential. CBD and Pain: Research on CBD salves remains limited. One small study found topical CBD improved pain compared with placebo, with results similar to diclofenac gel.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.